Glutathione-Responsive Multilayer Coated Gold Nanoparticles for Targeted Gene Delivery.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Biomedical Nanotechnology

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1166/JBN.2016.2177PMID 27280248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA

  2014cited by this paper
• Long-term efficient gene delivery using polyethylenimine with modified Tat peptide.

  2014cited by this paper
• A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery.

  2013cited by this paper
• Colorimetric sensing strategy for mercury(II) and melamine utilizing cysteamine-modified gold nanoparticles.

  2013cited by this paper
• Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery

  2013cited by this paper
• In situ preparation of gold nanoparticle-loaded lysozyme-dextran nanogels and applications for cell imaging and drug delivery.

  2013cited by this paper
• Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.

  2012cited by this paper
• The forthcoming applications of gold nanoparticles in drug and gene delivery systems.

  2011cited by this paper
• Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

  2011cited by this paper
• Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.

  2011cited by this paper
• Colorimetric detection of melamine in complex matrices based on cysteamine-modified gold nanoparticles.

  2011cited by this paper
• Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery.

  2011cited by this paper
• Dual redox responsive assemblies formed from diselenide block copolymers.

  2010cited by this paper
• Gold nanoparticle platforms as drug and biomacromolecule delivery systems.

  2010cited by this paper
• Low molecular weight polyethylenimine conjugated gold nanoparticles as efficient gene vectors.

  2010cited by this paper
• Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats.

  2010cited by this paper
• Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.

  2010cited by this paper
• Redox-sensitive disassembly of amphiphilic copolymer based micelles.

  2010cited by this paper
• Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors.

  2010cited by this paper
• Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.

  2010cited by this paper
• Layer-by-layer assembled gold nanoparticles for siRNA delivery.

  2009cited by this paper
• Protracted elimination of gold nanoparticles from mouse liver.

  2009cited by this paper
• Stabilization of polymer-hydrogel capsules via thiol-disulfide exchange.

  2009cited by this paper
• Carbon nanotube/gold nanoparticles/polyethylenimine-functionalized ionic liquid thin film composites for glucose biosensing.

  2008cited by this paper
• Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles.

  2008cited by this paper
• HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery.

  2008cited by this paper
• Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.

  2008cited by this paper
• Cell-penetrating and cell-targeting peptides in drug delivery.

  2008cited by this paper
• Disassembly of layer-by-layer films of plasmid DNA and reducible TAT polypeptide.

  2007cited by this paper
• Extinction coefficient of gold nanoparticles with different sizes and different capping ligands.

  2007cited by this paper
• Addition of a C-Terminal Cysteine Improves the Anti-Herpes Simplex Virus Activity of a Peptide Containing the Human Immunodeficiency Virus Type 1 TAT Protein Transduction Domain

  2007cited by this paper
• Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers.

  2006cited by this paper
• Stability of Gold Nanoparticle‐Bound DNA toward Biological, Physical, and Chemical Agents

  2006cited by this paper
• Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes.

  2005cited by this paper
• Enantioselective luminescence quenching of DNA light-switch [Ru(phen)2dppz]2+ by electron transfer to structural homologue [Ru(phendione)2dppz]2+.

  2005cited by this paper
• Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations.

  2002cited by this paper
• A Potent New Class of Reductively Activated Peptide Gene Delivery Agents*

  2000cited by this paper

• Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.

  2023cites this paper
• Thiol functionalised gold nanoparticles loaded with methotrexate for cancer treatment: From synthesis to in vitro studies on neuroblastoma cell lines.

  2023cites this paper
• A self-coated hollow mesoporous silica nanoparticle for tumor targeting and chemo-photothermal therapy

  2022cites this paper
• Tailored gold nanoparticles for improved control over drug release

  2022cites this paper
• Functional Nanoparticles for Enhanced Cancer Therapy

  2022cites this paper
• Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment

  2021cites this paper
• Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

  2021cites this paper
• Hybrid Nanosystems for Biomedical Applications.

  2021cites this paper
• Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.

  2020cites this paper
• Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy.

  2019cites this paper
• A conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma.

  2019cites this paper
• Redox/pH dual‐stimuli responsive camptothecin prodrug nanogels for “on‐demand” drug delivery

  2019cites this paper
• Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy.

  2019cites this paper
• Reduction‐sensitive mixed micelles for selective intracellular drug delivery to tumor cells and reversal of multidrug resistance

  2018cites this paper
• CHAPTER SEVEN Gold Nanoparticles for the Delivery of Cancer Therapeutics

  2018cites this paper
• NIR-Responsive Copolymer Upconversion Nanocomposites for Triggered Drug Release in Vitro and in Vivo.

  2018cites this paper
• Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities

  2018cites this paper
• Nanocarriers for Vaccine and Gene Delivery Application

  2018cites this paper
• Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor

  2018cites this paper
• Solvent-assisted in situ synthesis of cysteamine-capped silver nanoparticles

  2017cites this paper
• Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy.

  2017cites this paper